Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis.
about
Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.Profiling early lung immune responses in the mouse model of tuberculosis.CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.The adaptor molecule CARD9 is essential for tuberculosis control.Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.MCP1 haplotypes associated with protection from pulmonary tuberculosis.Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection.Presence of RD149 deletions in M. tuberculosis Central Asian Strain 1 isolates affect growth and TNFα induction in THP-1 monocytes.An interferon-related signature in the transcriptional core response of human macrophages to Mycobacterium tuberculosis infection.Beyond macrophages: the diversity of mononuclear cells in tuberculosis.Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections.The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceContribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression.Monocyte trafficking in acute and chronic inflammation.Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.Chemokines shape the immune responses to tuberculosis.Life and death in the granuloma: immunopathology of tuberculosis.Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection.Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.Essential yet limited role for CCR2⁺ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming.Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines.Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-InfectionThe onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression.MCP-1 -2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients.Cytokines and Chemokines in Mycobacterium tuberculosis Infection.Lysosomal phospholipase A2: a novel player in host immunity to Mycobacterium tuberculosis.Mycobacterium bovis bacilli Calmette-Guerin regulates leukocyte recruitment by modulating alveolar inflammatory responses.Mycobacterial mammalian cell entry protein 1A (Mce1A)-mediated adherence enhances the chemokine production by A549 alveolar epithelial cells.Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.Dielectrophoretic Separation of Live and Dead Monocytes Using 3D Carbon-Electrodes.Increased neutrophil influx but no impairment of protective immunity to tuberculosis in mice lacking the CD44 molecule.Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
P2860
Q24816509-50CCC4AE-6BBB-46F9-83CA-C49392B5EB2EQ30494609-5B27E2FB-17E5-4BA7-9922-1A59C14D2B65Q30996626-715CEDA2-A5B6-47EF-80CB-CBA13F381A53Q33521270-0CF6A402-E156-4F70-8C39-E3420FA620B0Q33794955-D339840C-E8B8-400C-87B7-B982BBF54161Q33826578-464AE7B9-BAE3-4E3F-A4DC-C4003961CA98Q33876943-C8D3AC16-2164-46BE-8331-65F1DA354134Q33886336-8DB880E2-7970-4792-84F5-8085764C5F9BQ34014503-C980AC13-F02E-45FF-8E07-47018892B7B1Q34295853-FAB0865C-79C6-46B3-A7BD-BBD0963BCABCQ34372502-85A7223B-442F-46BF-ABB6-44D59F2B59AEQ34490941-2A060E83-A31F-46B1-A836-BCBC05DA3854Q35043659-212E0588-EA50-46D2-9703-D4C944176223Q35083799-C2618F5E-A69B-4B62-9238-56E6772D10C0Q35228323-CD89907B-5325-4A6A-B987-65B380949717Q35230750-1F579E3D-BD7C-4B46-9678-2F710904526CQ36019386-288245B3-BAD7-4648-B9A5-0A382B9F36C6Q36640097-6AF07A7C-9D5D-4568-8899-44ADF2F80F62Q36703585-1FE7C98D-9149-4FE8-9981-D68DDFC5CEA7Q36853424-6D5E0DDB-0406-4AFA-A9C4-150EA977CFF9Q37256082-569239A2-AA7A-4945-9C1A-628DE0D354E2Q37289516-3C65E8DD-7289-436C-90E2-3C026C49B77FQ37651571-89B1E8DD-CD90-4A1C-8840-0CB01175F5FCQ38151096-D0E6DD99-E947-47E5-937A-AE57A085B3F5Q38363790-2D2C1622-7BB2-4E4E-B45D-BB876DA3B954Q38902921-FCEC4EA9-3070-45B4-8F24-3A8194638C7EQ38986062-E59F9BFE-760C-4C35-BA59-02342104A79AQ39437874-CF37445D-FDF6-44CC-99FB-7499E2723D15Q39447138-75599C7B-AB76-4183-8FD9-BD96C30FC042Q40169338-1B5E2020-AAF6-45A2-851B-80460C5379CFQ42067111-91872FD8-D7BA-4AD4-A35C-1BDA89FD9F08Q47115377-8828C372-31C4-40E6-AD47-A936AAB6F1C8Q47627753-B450FB0E-12B2-47F3-9BE6-622BDE01CACCQ51201248-3EBBE2A3-9A5A-4472-85BE-33EBF50B3574
P2860
Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@en
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@nl
type
label
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@en
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@nl
prefLabel
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@en
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@nl
P2860
P1433
P1476
Role of chemokine ligand 2 in ...... murine pulmonary tuberculosis.
@en
P2093
Ian M Orme
Randall J Basaraba
P2860
P304
P356
10.1046/J.1365-2567.2003.01680.X
P577
2003-08-01T00:00:00Z